TY - JOUR
T1 - HLA studies in fibromyalgia
AU - Branco, Jaime
AU - Tavares, Viviana
AU - Abreu, Isabel
AU - Correia, Maria Manuela
AU - Machado Caetano, J. A.
PY - 1996
Y1 - 1996
N2 - Objective Fibromyalgia Syndrome [FMS] is a prevalent rheumatic disorder whose etiology and pathogenesis remains largely unknown. Two previous studies have reported familial clustering of FMS cases and patients with history of "rheumatism" and/or arthritis in first degree relatives. Another study showed the association of HLA-DR4 antigens in FMS patients, a finding not confirmed in subsequent larger studies. The objective of this study was to investigate the possible association of FMS with individual class I [loci A, B and C] and class II [DR] human leukocyte antigen [HLA] antigens. Methods: HLA-typing was determined in fifty-two FMS patients [49 females; mean age 46.7 years ±8.9]. All FMS patients met the American College of Rheumatology 1990 classification criteria. Patients were compared with a control group of 869 normal individuals. Loci A and B were determined in all the control population, locus C in 832 and locus DR in 344 of those individuals. All loci were studied by National Institutes of Health [NIH] microlymphocytotoxicity technique. Results: Significant positive associations were noted between FMS patients and HLA B58 [RR = 18.0; pc = 0.0004], DR5 [RR = 3.6; pc = 0.003] and DR8 [RR = 14.8; pc = 0.001]. No other HLA associations, including DR4 antigens, were noted in FMS patients. Conclusions: In our study FMS was associated with individual B58, DR5 and DR8 HLA antigens. Our findings suggest the possibility of immunogenetic factors in FMS pathogcnesis. However, the difference between our results and those of former studies suggests the heterogeneity among FMS populations and the need for further investigation.
AB - Objective Fibromyalgia Syndrome [FMS] is a prevalent rheumatic disorder whose etiology and pathogenesis remains largely unknown. Two previous studies have reported familial clustering of FMS cases and patients with history of "rheumatism" and/or arthritis in first degree relatives. Another study showed the association of HLA-DR4 antigens in FMS patients, a finding not confirmed in subsequent larger studies. The objective of this study was to investigate the possible association of FMS with individual class I [loci A, B and C] and class II [DR] human leukocyte antigen [HLA] antigens. Methods: HLA-typing was determined in fifty-two FMS patients [49 females; mean age 46.7 years ±8.9]. All FMS patients met the American College of Rheumatology 1990 classification criteria. Patients were compared with a control group of 869 normal individuals. Loci A and B were determined in all the control population, locus C in 832 and locus DR in 344 of those individuals. All loci were studied by National Institutes of Health [NIH] microlymphocytotoxicity technique. Results: Significant positive associations were noted between FMS patients and HLA B58 [RR = 18.0; pc = 0.0004], DR5 [RR = 3.6; pc = 0.003] and DR8 [RR = 14.8; pc = 0.001]. No other HLA associations, including DR4 antigens, were noted in FMS patients. Conclusions: In our study FMS was associated with individual B58, DR5 and DR8 HLA antigens. Our findings suggest the possibility of immunogenetic factors in FMS pathogcnesis. However, the difference between our results and those of former studies suggests the heterogeneity among FMS populations and the need for further investigation.
KW - Fibromyalgia
KW - Hla antigens
UR - http://www.scopus.com/inward/record.url?scp=0029684121&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:0029684121
SN - 1058-2452
VL - 4
SP - 21
EP - 27
JO - Journal of Musculoskeletal Pain
JF - Journal of Musculoskeletal Pain
IS - 3
ER -